Controversies in the Assessment of Minimal Residual Disease in Multiple Myeloma: Clinical Significance of Minimal Residual Disease Negativity Using Highly Sensitive Techniques
Crossref DOI link: https://doi.org/10.1007/s11899-014-0237-y
Published Online: 2014-09-16
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Biran, Noa
Ely, Scott
Chari, Ajai
Text and Data Mining valid from 2014-09-16